GB Sciences, Inc. (OTCMKTS:GBLX) Short Interest Update

GB Sciences, Inc. (OTCMKTS:GBLXGet Rating) saw a significant increase in short interest in May. As of May 31st, there was short interest totalling 48,600 shares, an increase of 159.9% from the May 15th total of 18,700 shares. Based on an average daily volume of 299,500 shares, the days-to-cover ratio is currently 0.2 days.

Shares of GBLX opened at $0.03 on Friday. The business’s fifty day moving average is $0.03 and its 200-day moving average is $0.03. GB Sciences has a 52-week low of $0.02 and a 52-week high of $0.07.

GB Sciences Company Profile (Get Rating)

GB Sciences, Inc engages in the research and development of cannabinoid medicines in North America and Europe. Its intellectual property covers a range of conditions and programs in pre-clinical animal stage for Parkinson's disease, neuropathic pain, and cardiovascular therapeutic programs. The company was formerly known as Growblox Sciences, Inc and changed its name to GB Sciences, Inc in October 2016.

Read More

Receive News & Ratings for GB Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GB Sciences and related companies with MarketBeat.com's FREE daily email newsletter.